Kirson Eilon D.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$40.17M

Insider Activity of Kirson Eilon D.

The largest sale of all time was on 2018-06-04 and amounted to 692322 shares of NovoCure Limited for $20.01M.

Biography of Kirson Eilon D.

No biography is available at this moment.

2019-01-17SaleNovoCure Limited
NVCR
Chief Science Officer
137,626
0.1451%
$45.25$6.23M+53.4%
2019-01-16SaleNovoCure Limited
NVCR
Chief Science Officer
200,000
0.1386%
$29.74$5.95M+53.04%
2018-06-04SaleNovoCure Limited
NVCR
Chief Science Officer
692,322
0.7413%
$28.90$20.01M+48.46%
2018-04-18SaleNovoCure Limited
NVCR
Chief Science Officer
147,825
0.0905%
$13.31$1.97M+53.36%
2018-01-11SaleNovoCure Limited
NVCR
Chief Science Officer
50,640
0.0559%
$22.00$1.11M+42.33%
2017-11-06SaleNovoCure Limited
NVCR
Chief Science Officer
9,100
0.0104%
$22.00$200,200+33.49%
2017-11-03SaleNovoCure Limited
NVCR
Chief Science Officer
6,200
0.007%
$22.00$136,400+29.59%
2017-11-02SaleNovoCure Limited
NVCR
Chief Science Officer
600
0.0007%
$22.00$13,200+28.65%
2017-11-01SaleNovoCure Limited
NVCR
Chief Science Officer
44,238
0.0507%
$22.01$973,621+30.47%
2017-10-31SaleNovoCure Limited
NVCR
Chief Science Officer
300
0.0003%
$22.00$6,600+29.63%
2017-06-21SaleNovoCure Limited
NVCR
Chief Science Officer
132,722
0.1442%
$16.77$2.23M+17.14%
2017-06-19SaleNovoCure Limited
NVCR
Chief Science Officer
30,000
0.0324%
$15.06$451,770+29.75%
2017-06-13SaleNovoCure Limited
NVCR
Chief Science Officer
18,088
0.0204%
$15.01$271,537+35.6%
2017-06-12SaleNovoCure Limited
NVCR
Chief Science Officer
11,912
0.0138%
$15.08$179,657+38.47%
2017-06-09SaleNovoCure Limited
NVCR
Chief Science Officer
30,000
0.0334%
$15.02$450,450+33.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.